AffiAB® Goat anti-NSP12 Polyclonal IgG Antibody is designed to specifically bind to the NSP12 (SARS-CoV-2) protein. This highly efficient antibody is optimized for use in Western blot and ELISA assays for detecting and quantifying NSP12 (SARS-CoV-2) proteins.
The AffiAB® Goat anti-NSP12 (SARS-CoV-2) Polyclonal IgG Antibody is a specific antibody designed to target and detect the NSP12 protein of the SARS-CoV-2 virus. NSP12 (non-structural protein 12), also known as RNA-dependent RNA polymerase (RdRp), is a crucial enzyme involved in viral RNA replication.
This polyclonal antibody is generated by immunizing goats with purified NSP12 protein or a specific peptide sequence derived from NSP12. The resulting antibody is then purified from goat serum using various purification techniques to ensure high specificity and quality.
The AffiAB® Goat anti-NSP12 (SARS-CoV-2) Polyclonal IgG Antibody is widely used in research and diagnostic applications to investigate the SARS-CoV-2 virus. It can be utilized in techniques such as Western blotting, immunohistochemistry, immunofluorescence, and ELISA to detect and analyze NSP12 protein expression in infected cells or patient samples.
By specifically targeting NSP12, this antibody enables researchers to study the localization, expression levels, and functional roles of NSP12 during SARS-CoV-2 infection. Understanding the properties of NSP12 and its interaction with other viral proteins is crucial for unraveling the viral replication mechanism and developing potential antiviral strategies.
In summary, the AffiAB® Goat anti-NSP12 (SARS-CoV-2) Polyclonal IgG Antibody is a valuable tool for scientists investigating the SARS-CoV-2 virus. Its high specificity and sensitivity make it suitable for various applications in virology, immunology, and COVID-19 research.